1,015
Participants
Start Date
July 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
25 mg/day AVE5530
"* one tablet in the evening with dinner~* in addition to statin treatment (HMG-CoA Reductase Inhibitors)"
50 mg/day AVE5530
"* one tablet in the evening with dinner~* in addition to statin treatment (HMG-CoA Reductase Inhibitors)"
placebo
"* one tablet in the evening with dinner~* in addition to statin treatment (HMG-CoA Reductase Inhibitors)"
Sanofi-Aventis Administrative Office, Bridgewater
sanofi-aventis Australia & New Zealand administrative office, Macquarie Park
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Netanya
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Moscow
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Bromma
Lead Sponsor
Sanofi
INDUSTRY